James Darecca's Net Worth
$99.6 Thousand
Who is James Darecca?
James Darecca does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HAEMONETICS CORP, Actavis plc, TherapeuticsMD, Inc., Prestige Consumer Healthcare Inc., and Actavis, Inc..
SEC CIK
James Darecca's CIK is 0001583903
Past Insider Trading and Trends
2020 was James Darecca's most active year for acquiring shares with 5 total transactions. James Darecca's most active month to acquire stocks was the month of February. 2017 was James Darecca's most active year for disposing of shares, totalling 7 transactions. James Darecca's most active month to dispose stocks was the month of February. 2020 saw James Darecca paying a total of $699,956.24 for 1,609,611 shares, this is the most they've acquired in one year. In 2020 James Darecca cashed out on 20,213 shares for a total of $137,820.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HAEMONETICS CORP (HAE) Snapshot price: $73.24
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.39% | 4.44K |
—
|
—
| 17.35K |
May 17
| |||
Form 4
| -5.58% | -763.00 |
$95.71 | -$73,028.68 | 12.91K |
May 15 - May 16
| |||
Form 4
| -3.06% | -432.00 |
$93.33 | -$40,318.56 | 13.67K |
May 2
| |||
Form 4
| +37.63% | 3.86K |
$89.21 | -$31,134.29 | 14.1K |
May 15 - May 16
| |||
Form 4
| -4.03% | -430.00 |
$81.66 | -$35,113.80 | 10.25K |
May 2
| |||
Form 4
| +80.89% | 4.77K |
—
|
—
| 10.68K |
May 16
| |||
Form 4
|
∞
| 5.9K |
—
|
—
| 5.9K |
May 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actavis plc No price found
SVP Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.84K |
—
|
—
|
0
|
May 8
| |||
Form 4
| -6.80% | -718.00 |
$191.95 | -$137,820.10 | 9.83K |
Mar 6
| |||
Form 4
| +52.02% | 3.61K |
$193.84 | $699,956.24 | 10.55K |
Mar 2
| |||
Form 4
| -1.31% | -92.00 |
$191.17 | -$17,587.64 | 6.94K |
Dec 31
| |||
Form 4
| -6.29% | -472.00 |
$143.49 | -$67,728.78 | 7.03K |
Mar 7 - Mar 8
| |||
Form 4
| +37.23% | 2.04K |
$137.51 | $279,970.36 | 7.5K |
Mar 6
| |||
Form 4
| -2.04% | -114.00 |
$139.12 | -$15,859.68 | 5.47K |
Mar 4
| |||
Form 4/A
| +45.84% | 1.83K |
$153.22 | $279,779.72 | 5.81K |
Mar 7
| |||
Form 4
| -2.63% | -147.00 |
$133.66 | -$19,648.02 | 5.45K |
Dec 31
| |||
Form 4
| -1.39% | -79.00 |
$153.50 | -$12,126.50 | 5.6K |
Mar 8
| |||
Form 4
| +39.33% | 1.6K |
$153.22 | $245,611.66 | 5.68K |
Mar 7
| |||
Form 4
| -3.46% | -146.00 |
$146.28 | -$21,356.62 | 4.08K |
Mar 2 - Mar 5
| |||
Form 4
| -2.31% | -100.00 |
$163.58 | -$16,358.00 | 4.22K |
Dec 29
| |||
Form 4
| +22.68% | 799 |
—
|
—
| 4.32K |
Oct 26
| |||
Form 4
| +40.08% | 1.01K |
$239.52 | $241,529.12 | 3.52K |
Mar 7 - Mar 8
| |||
Form 4
| -5.20% | -138.00 |
$245.63 | -$33,896.94 | 2.52K |
Mar 4 - Mar 5
| |||
Form 4
| +5.82% | 146 |
$229.32 | $33,480.72 | 2.65K |
Feb 1
| |||
Form 4
| +57.38% | 914 |
$284.43 | $259,969.02 | 2.51K |
Mar 8
| |||
Form 4
| +31.11% | 378 |
$295.70 | -$23,064.60 | 1.59K |
Mar 5
| |||
Form 4
| +259.47% | 877 |
$296.14 | $259,714.78 | 1.22K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 338 |
$197.05 | $66,602.90 | 338 |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TherapeuticsMD, Inc. (TXMD) Snapshot price: $1.9
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 123.83K |
$0.87 | -$81,203.19 | 123.83K |
Aug 10 - Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prestige Consumer Healthcare Inc. (PBH) Snapshot price: $74.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.95% | 2.2K |
—
|
—
| 4.5K |
Aug 6
| |||
Form 4
|
∞
| 2.29K |
—
|
—
| 2.29K |
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actavis, Inc. No price found
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||